Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 30% ± 11% | |
dendritic cell | 4 studies | 31% ± 9% | |
conventional dendritic cell | 3 studies | 27% ± 7% | |
endothelial cell | 3 studies | 23% ± 6% | |
ciliated cell | 3 studies | 24% ± 4% | |
basal cell | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4484.18 | 1445 / 1445 | 100% | 59.86 | 183 / 183 |
liver | 100% | 3586.57 | 226 / 226 | 100% | 50.68 | 406 / 406 |
lung | 100% | 4524.30 | 578 / 578 | 100% | 68.91 | 1155 / 1155 |
ovary | 100% | 5961.79 | 180 / 180 | 100% | 64.50 | 430 / 430 |
pancreas | 100% | 2959.70 | 328 / 328 | 100% | 59.14 | 178 / 178 |
prostate | 100% | 6854.09 | 245 / 245 | 100% | 67.42 | 502 / 502 |
skin | 100% | 5097.66 | 1809 / 1809 | 100% | 90.64 | 472 / 472 |
stomach | 100% | 3732.01 | 359 / 359 | 100% | 66.42 | 286 / 286 |
thymus | 100% | 8573.42 | 653 / 653 | 100% | 60.00 | 605 / 605 |
uterus | 100% | 5296.36 | 170 / 170 | 100% | 76.83 | 459 / 459 |
breast | 100% | 4731.51 | 459 / 459 | 100% | 70.85 | 1117 / 1118 |
kidney | 100% | 6588.15 | 89 / 89 | 100% | 57.90 | 900 / 901 |
intestine | 100% | 4819.72 | 966 / 966 | 100% | 75.14 | 525 / 527 |
adrenal gland | 100% | 5765.99 | 258 / 258 | 100% | 55.25 | 229 / 230 |
bladder | 100% | 4548.29 | 21 / 21 | 99% | 78.36 | 501 / 504 |
brain | 99% | 3824.73 | 2619 / 2642 | 100% | 72.19 | 705 / 705 |
adipose | 100% | 4513.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 69.03 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 89.44 | 29 / 29 |
spleen | 100% | 7075.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 64.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.41 | 1 / 1 |
blood vessel | 100% | 3640.69 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3026.65 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2610.11 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2929.09 | 891 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051607 | Biological process | defense response to virus |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_0006364 | Biological process | rRNA processing |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0044830 | Biological process | modulation by host of viral RNA genome replication |
GO_0005730 | Cellular component | nucleolus |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0035613 | Molecular function | RNA stem-loop binding |
GO_0005515 | Molecular function | protein binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | DDX56 |
Protein name | DEAD-box helicase 56 RNA helicase (EC 3.6.4.13) Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56) |
Synonyms | hCG_18300 NOH61 DDX21 |
Description | FUNCTION: Nucleolar RNA helicase that plays a role in various biological processes including innate immunity, ribosome biogenesis or nucleolus organization . Plays an essential role in maintaining nucleolar integrity in planarian stem cells . Maintains embryonic stem cells proliferation by conventional regulation of ribosome assembly and interaction with OCT4 and POU5F1 complex (By similarity). Regulates antiviral innate immunity by inhibiting the virus-triggered signaling nuclear translocation of IRF3 . Mechanistically, acts by disrupting the interaction between IRF3 and importin IPO5 . May play a role in later stages of the processing of the pre-ribosomal particles leading to mature 60S ribosomal subunits. Has intrinsic ATPase activity. .; FUNCTION: (Microbial infection) Helicase activity is important for packaging viral RNA into virions during West Nile virus infection. .; FUNCTION: (Microbial infection) Plays a positive role in foot-and-mouth disease virus replication by inhibiting the phosphorylation of IRF3 leading to inhibition of type I interferon. .; FUNCTION: (Microbial infection) Plays a positive role in EMCV replication by interrupting IRF3 phosphorylation and its nucleus translocation. . |
Accessions | H7BZN7 H7C3E9 ENST00000415758.1 G3V0G3 ENST00000446987.5 ENST00000448192.1 ENST00000433257.5 Q9NY93 ENST00000421223.5 ENST00000431640.5 [Q9NY93-2] F8WEI3 F8WDT8 ENST00000258772.10 [Q9NY93-1] |